메뉴 건너뛰기




Volumn 434, Issue 1-2, 2012, Pages 429-436

PEGylation of an osteoclast inhibitory peptide: Suitable candidate for the treatment of osteoporosis

Author keywords

Bioavailability; PEGylated peptide; RANK; TRAF 6 Inhibitory peptide

Indexed keywords

PEGYLATED TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6 INHIBITORY PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

EID: 84864127212     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.012     Document Type: Article
Times cited : (4)

References (30)
  • 1
    • 0035857351 scopus 로고    scopus 로고
    • Osteoporosis prevention, diagnosis, and therapy
    • JAMA
    • JAMA Osteoporosis prevention, diagnosis, and therapy JAMA 2001 785 795
    • (2001) JAMA , pp. 785-795
  • 2
    • 0037113931 scopus 로고    scopus 로고
    • A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function
    • A.P. Armstrong, M.E. Tometsko, M. Glaccum, C.L. Sutherland, D. Cosman, and W.C. Dougall A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function J. Biol. Chem. 277 2002 44347 44356
    • (2002) J. Biol. Chem. , vol.277 , pp. 44347-44356
    • Armstrong, A.P.1    Tometsko, M.E.2    Glaccum, M.3    Sutherland, C.L.4    Cosman, D.5    Dougall, W.C.6
  • 4
    • 0032746314 scopus 로고    scopus 로고
    • Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
    • B.G. Darnay, and B.B. Aggarwal Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors Ann. Rheum. Dis. 58 1999 I2 I13
    • (1999) Ann. Rheum. Dis. , vol.58
    • Darnay, B.G.1    Aggarwal, B.B.2
  • 7
    • 0029993066 scopus 로고    scopus 로고
    • Altered biodistribution of an antibody-enzyme conjugate modified with polyethylene glycol
    • E.A. Eno-Amooquaye, F. Searle, J.A. Boden, S.K. Sharma, and P.J. Burke Altered biodistribution of an antibody-enzyme conjugate modified with polyethylene glycol Br. J. Cancer 73 1996 1323 1327
    • (1996) Br. J. Cancer , vol.73 , pp. 1323-1327
    • Eno-Amooquaye, E.A.1    Searle, F.2    Boden, J.A.3    Sharma, S.K.4    Burke, P.J.5
  • 8
    • 0034691645 scopus 로고    scopus 로고
    • Biodistribution of fluorescinated dextran using novel nanoparticles evading reticuloendothelial system
    • U. Gaur, S.K. Sahoo, T.K. De, P.C. Ghosh, A. Maitra, and P.K. Ghosh Biodistribution of fluorescinated dextran using novel nanoparticles evading reticuloendothelial system Int. J. Pharm. 202 2000 1 10
    • (2000) Int. J. Pharm. , vol.202 , pp. 1-10
    • Gaur, U.1    Sahoo, S.K.2    De, T.K.3    Ghosh, P.C.4    Maitra, A.5    Ghosh, P.K.6
  • 9
    • 0029798819 scopus 로고    scopus 로고
    • Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta
    • D.E. Hughes, A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy, and B.F. Boyce Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta Nat. Med. 2 1996 1132 1136
    • (1996) Nat. Med. , vol.2 , pp. 1132-1136
    • Hughes, D.E.1    Dai, A.2    Tiffee, J.C.3    Li, H.H.4    Mundy, G.R.5    Boyce, B.F.6
  • 11
    • 0001365675 scopus 로고
    • Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model
    • N.V. Katre, M.J. Knauf, and W.J. Laird Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model Proc. Natl. Acad. Sci. U.S.A. 84 1987 1487 1491
    • (1987) Proc. Natl. Acad. Sci. U.S.A. , vol.84 , pp. 1487-1491
    • Katre, N.V.1    Knauf, M.J.2    Laird, W.J.3
  • 12
    • 0035206443 scopus 로고    scopus 로고
    • Minireview: The OPG/RANKL/RANK system
    • S. Khosla Minireview: the OPG/RANKL/RANK system Endocrinology 142 2001 5050 5055
    • (2001) Endocrinology , vol.142 , pp. 5050-5055
    • Khosla, S.1
  • 13
    • 0026536995 scopus 로고
    • Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis
    • M.M. Kurfurst Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis Anal. Biochem. 200 1992 244 248
    • (1992) Anal. Biochem. , vol.200 , pp. 244-248
    • Kurfurst, M.M.1
  • 16
    • 0026926609 scopus 로고
    • Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo
    • H. Maeda, L.W. Seymour, and Y. Miyamoto Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjug. Chem. 3 1992 351 362
    • (1992) Bioconjug. Chem. , vol.3 , pp. 351-362
    • Maeda, H.1    Seymour, L.W.2    Miyamoto, Y.3
  • 17
    • 34548413629 scopus 로고    scopus 로고
    • Role of RANKL inhibition in osteoporosis
    • M. McClung Role of RANKL inhibition in osteoporosis Arthritis Res. Ther. 9 2007 S3
    • (2007) Arthritis Res. Ther. , vol.9 , pp. 3
    • McClung, M.1
  • 18
    • 33748918574 scopus 로고    scopus 로고
    • Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs
    • S. Parveen, and S.K. Sahoo Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs Clin. Pharmacokinet. 45 2006 965 988
    • (2006) Clin. Pharmacokinet. , vol.45 , pp. 965-988
    • Parveen, S.1    Sahoo, S.K.2
  • 19
    • 34250200793 scopus 로고    scopus 로고
    • Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides
    • A.T. Poblenz, J.J. Jacoby, S. Singh, and B.G. Darnay Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides Biochem. Biophys. Res. Commun. 359 2007 510 515
    • (2007) Biochem. Biophys. Res. Commun. , vol.359 , pp. 510-515
    • Poblenz, A.T.1    Jacoby, J.J.2    Singh, S.3    Darnay, B.G.4
  • 20
    • 33751218547 scopus 로고    scopus 로고
    • Therapeutic peptides: Technological advances driving peptides into development
    • A.K. Sato, M. Viswanathan, R.B. Kent, and C.R. Wood Therapeutic peptides: technological advances driving peptides into development Curr. Opin. Biotechnol. 17 2006 638 642
    • (2006) Curr. Opin. Biotechnol. , vol.17 , pp. 638-642
    • Sato, A.K.1    Viswanathan, M.2    Kent, R.B.3    Wood, C.R.4
  • 22
    • 35148889105 scopus 로고    scopus 로고
    • Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
    • M. Terauchi, H. Kajiyama, K. Shibata, K. Ino, A. Nawa, S. Mizutani, and F. Kikkawa Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells BMC Cancer 7 2007 140
    • (2007) BMC Cancer , vol.7 , pp. 140
    • Terauchi, M.1    Kajiyama, H.2    Shibata, K.3    Ino, K.4    Nawa, A.5    Mizutani, S.6    Kikkawa, F.7
  • 24
    • 0035284411 scopus 로고    scopus 로고
    • Peptide and protein PEGylation: A review of problems and solutions
    • F.M. Veronese Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22 2001 405 417
    • (2001) Biomaterials , vol.22 , pp. 405-417
    • Veronese, F.M.1
  • 25
    • 0032870935 scopus 로고    scopus 로고
    • Bioconjugation in pharmaceutical chemistry
    • F.M. Veronese, and M. Morpurgo Bioconjugation in pharmaceutical chemistry Farmaco 54 1999 497 516
    • (1999) Farmaco , vol.54 , pp. 497-516
    • Veronese, F.M.1    Morpurgo, M.2
  • 26
    • 26944452043 scopus 로고    scopus 로고
    • PEGylation, successful approach to drug delivery
    • F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov. Today 10 2005 1451 1458
    • (2005) Drug Discov. Today , vol.10 , pp. 1451-1458
    • Veronese, F.M.1    Pasut, G.2
  • 28
    • 0030802506 scopus 로고    scopus 로고
    • The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
    • R.S. Weinstein, R.L. Jilka, A.M. Parfitt, and S.C. Manolagas The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage Endocrinology 138 1997 4013 4021
    • (1997) Endocrinology , vol.138 , pp. 4013-4021
    • Weinstein, R.S.1    Jilka, R.L.2    Parfitt, A.M.3    Manolagas, S.C.4
  • 29
    • 33745107170 scopus 로고    scopus 로고
    • Strategies to improve plasma half life time of peptide and protein drugs
    • M. Werle, and A. Bernkop-Schnurch Strategies to improve plasma half life time of peptide and protein drugs Amino Acids 30 2006 351 367
    • (2006) Amino Acids , vol.30 , pp. 351-367
    • Werle, M.1    Bernkop-Schnurch, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.